European Medicines Agency

Ljubljana – Slovenia’s national medical ethics committee has no reservations towards Lagevrio, a medicine also known as molnupiravir. The committee maintains that the drug brings significant progress in fighting the coronavirus epidemic, as it prevents a severe course of Covid-19 or death.

The European Medicines Agency said today it had begun reviewing a new vaccine against COVID-19, produced by the French company Valneva - the first step towards approving its use in the European Union, the Associated Press reported.

The European drug regulator announced on Tuesday that it would approve vaccines adapted to Covid's new version, Omicron, within three to four months if necessary, but existing drugs would continue to provide protection, Reuters reported.

The Commission for Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EDA) has recommended that the use of the Comirnaty vaccine by Biontech / Pfizer against COVID-19 be given to children aged 5 to 11 years.

The vaccine is already used on children that are 12 years old.

On Friday, the EU medicines supervisor said countries could use Merck's covid pill in emergencies caused by the growing number of cases before treatment is officially approved across the bloc.

Breakthrough in drugs against COVID-19 by oral administration, in tablet form. At this stage we have two such molecules - one is molnupiravir, the other ritonavir. This was commented in "The day begins" Prof. Ilko Getov, Bulgarian representative in the European Medicines Agency.

Clinical trials have been conducted that show the drugs have excellent efficacy, he said.

The completed vaccination course, with any of the EU-approved vaccines, provides a high level of protection against the severe course of the disease and death caused by SARS-CoV-2, including infection with the Delta variant of the virus. This was announced by the Bulgarian Ministry of Health.

The European Medicines Agency has approved the administration of a booster dose of the Moderna vaccine.

The regulator concluded that booster doses could be given to individuals over 18 years of age at least six months after the second dose.

The European Medicines Agency (EMA) has announced that it will analyze data, including the results from an ongoing study, for a vaccine distributed under the name "Comirnaty". It is already approved for children older than 12 in the USA and the EU.

Ljubljana – Slovenia will follow the recommendation of the national advisory committee on immunisation to use the Pfizer vaccine for those under 30 years old, Health Minister Janez Poklukar said on Monday. In general, the use of mRNA vaccines will be recommended over viral vector vaccines.